New data, fantastic: Pfizer vaccine protects elderly people by 94%

The coronary vaccine developed by Pfizer and BioNTech appears to protect 94% of adults over the age of 65. More data was launched in the third phase of ongoing testing, and it is noted that this vaccine functions equally well in people of all ages, races, and ethnicities. Companies [...]
More data was launched in the third phase of ongoing testing, and it is noted that this vaccine functions equally well in people of all ages, races, and ethnicities.
Companies say they will now apply for authorisation to be used in emergency form in the US, writes BBC, translate Periscopi.
The findings were based on two doses given to more than 41,000 people worldwide.
Last week, Pfizer and BioNTech published preliminary data that showed that the vaccine offered 90 percent protection against Covid-19shi and that there was no concern over her safety.
This news was followed by the American Moderna company, which showed that its vaccine was 95 percent effective. /Periscope












